c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Bayer gains approval of Factor XIa inhibitor asundexian to reduce stroke risk
Seeking Alpha | Nov 9, 2026 9:08 PM EST
Read original article